Search results
Results From The WOW.Com Content Network
Seattle Genetics was founded in 1997, by Henry Perry Fell, Jr. and Clay Siegall, and is headquartered in Bothell, Washington, a suburb of Seattle. The company completed an initial public offering in March 2001, and is traded on the Nasdaq Stock Market under the symbol SGEN.
List of largest biomedical companies by market capitalization. The following is a list of independent pharmaceutical, biotechnology and medical companies listed on a stock exchange (as indicated) with current market capitalization of at least US$10 billion, ranked by their market capitalization. It does not include biotechnology companies that ...
Lundbeck Seattle Biopharmaceuticals is a pharmaceutical development company based in Bothell, Washington. Formerly known as Alder Biopharmaceuticals, it specializes in therapeutic monoclonal antibodies. In May 2014, Alder went public. [1] In early 2018, the company made a public stock offering, aiming to raise US$250 million. [2]
For premium support please call: 800-290-4726 more ways to reach us
This is a list of large or well-known interstate or international companies headquartered in the Seattle metropolitan area.. As of December 2021, the Seattle metropolitan area is home to ten Fortune 500 companies: Internet retailer Amazon (#2), Costco Wholesale (#12), Microsoft (#15), coffee chain Starbucks (#125), Paccar (#159), clothing merchant Nordstrom (#289), Weyerhaeuser (#387 ...
The stock market is generally going like gangbusters, reaching all-time highs. Stocks like Nvidia and Microsoft are forging the path. But with price-to-earnings (P/E) ratios of 73 and 39 ...
Lintuzumab (SGN-33) is a humanized monoclonal antibody used in the treatment of cancer. The drug had been developed by Seattle Genetics as a treatment for acute myeloid leukemia (AML), a condition which results in the deaths of 9,000 people a year in the United States. Lintuzumab targets the CD33 protein, which is expressed in AML and other ...
TECH STRENGTH ROLLS ON. One potential concern is that the market could be at risk if a few large tech companies that have driven a lion's share of the gains stop surprising to the upside. However ...